Easyjet PLC share price continues to fall after posting its first ever annual loss due to COVID-19
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get Premium without limits for only $9.99 for the first month
Access all our articles, insights, and analysts.
UNLOCK OFFER- LSE:EZJ dips by 0.84% as horrific year continues for the UK-based low-cost airline.
- European travel industry continues to get hammered despite recent COVID-19 vaccine news.
- Easyjet reports a year-over-year decrease of 52.9% in annual revenues.
LSE:EZJ continued its slide on Wednesday after a 7% drop on Tuesday following the first-ever annual losses reported by the discount airline brand that operates out of Luton Airport in London, England. Shares fell a further 0.84% as worsening cases of the COVID-19 virus spreading across Europe has put a damper on many of the discount airlines that operate on the continent. Easyjet’s stock has now fallen over 45% year to date and while it has still recovered over 84% since its 52-week lows of 410p, EZJ still has a lot of recovering to do to return to the levels it was trading at in 2019.
The fiscal year ending in September 2020 represented Easyjet’s first-ever annual loss as a company. A serious downturn in passenger volume and tickets purchased saw the year-over-year revenues fall from 6.38 billion to 3 billion, which represents a decrease of 52.9%. CEO Johan Lundgren also announced that only 20% of Easyjet’s scheduled flights for the rest of 2020 are expected to take-off, a sure sign that domestic and international travel are still a long way off, even if a vaccine is created.
Easyjet stock price
Easyjet is not the only British airline hit as British Airways owner IAG (LSE:IAG) also reported a near 80% decline in passengers during the most recent quarter. With areas of Western Europe and the UK having been hit especially hard by COVID-19, it should come as no surprise that these companies are struggling to get by. IAG has also seen its shares drop by over 70% during the past 52-weeks, having only recently rebounded slightly amidst news of the potential vaccines.
- LSE:EZJ dips by 0.84% as horrific year continues for the UK-based low-cost airline.
- European travel industry continues to get hammered despite recent COVID-19 vaccine news.
- Easyjet reports a year-over-year decrease of 52.9% in annual revenues.
LSE:EZJ continued its slide on Wednesday after a 7% drop on Tuesday following the first-ever annual losses reported by the discount airline brand that operates out of Luton Airport in London, England. Shares fell a further 0.84% as worsening cases of the COVID-19 virus spreading across Europe has put a damper on many of the discount airlines that operate on the continent. Easyjet’s stock has now fallen over 45% year to date and while it has still recovered over 84% since its 52-week lows of 410p, EZJ still has a lot of recovering to do to return to the levels it was trading at in 2019.
The fiscal year ending in September 2020 represented Easyjet’s first-ever annual loss as a company. A serious downturn in passenger volume and tickets purchased saw the year-over-year revenues fall from 6.38 billion to 3 billion, which represents a decrease of 52.9%. CEO Johan Lundgren also announced that only 20% of Easyjet’s scheduled flights for the rest of 2020 are expected to take-off, a sure sign that domestic and international travel are still a long way off, even if a vaccine is created.
Easyjet stock price
Easyjet is not the only British airline hit as British Airways owner IAG (LSE:IAG) also reported a near 80% decline in passengers during the most recent quarter. With areas of Western Europe and the UK having been hit especially hard by COVID-19, it should come as no surprise that these companies are struggling to get by. IAG has also seen its shares drop by over 70% during the past 52-weeks, having only recently rebounded slightly amidst news of the potential vaccines.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.